Publications by authors named "Marion LooSS"

Claim this Profile
I
IDHIRA: a prospective, observational study on ivosidenib in patients with R132-mutated advanced cholangiocarcinoma.
Marlies Michl, Nora Hagemeyer, Marion Looß, Sina Grebhardt, Kai Ringwald

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis